[The role of radiotherapy in the treatment of non-Hodgkin's lymphoma of the thyroid].
Retrospective analysis was made of 30 cases of non-Hodgkin's lymphoma treated from 1967 through 1983 at the Department of Radiology, Osaka University Hospital, according to the Ann Arbor staging classification modified by us. Overall five-year survival and five-year relapse-free survival were 62% and 60%, respectively, with one out of 9 cases treated since 1979 being lost due to relapse. In cases with disease localized in the thyroid and neck nodes (Stage IIE-a, by modified classification), five-year survival of 74% was obtained, whereas in those with the lesion extending to the mediastinum (IIE-b) or axillae (IIE-c), the survival pattern was similar to that with Stage II and IV. Complete local control was obtained in all cases by radiotherapy.
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000401:mortality / Q000532:radiotherapy* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011879:Radiotherapy Dosage; D011882:Radiotherapy, High-Energy; D013964:Thyroid Neoplasms / Q000401:mortality / Q000532:radiotherapy* / Q000628:therapy
D000970:Antineoplastic Agents